WO2016046795A1 - Protein dietary supplement - Google Patents
Protein dietary supplement Download PDFInfo
- Publication number
- WO2016046795A1 WO2016046795A1 PCT/IB2015/057382 IB2015057382W WO2016046795A1 WO 2016046795 A1 WO2016046795 A1 WO 2016046795A1 IB 2015057382 W IB2015057382 W IB 2015057382W WO 2016046795 A1 WO2016046795 A1 WO 2016046795A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dietary supplement
- protein
- plant extract
- weight
- supplement according
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 64
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 57
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 57
- 235000018102 proteins Nutrition 0.000 claims abstract description 55
- 239000000419 plant extract Substances 0.000 claims abstract description 53
- 241000196324 Embryophyta Species 0.000 claims abstract description 25
- 150000001413 amino acids Chemical class 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 20
- 241000522169 Lespedeza Species 0.000 claims abstract description 12
- 239000002671 adjuvant Substances 0.000 claims abstract description 12
- 230000001430 anti-depressive effect Effects 0.000 claims abstract description 10
- 239000000935 antidepressant agent Substances 0.000 claims abstract description 10
- 229940005513 antidepressants Drugs 0.000 claims abstract description 10
- 241000219726 Griffonia simplicifolia Species 0.000 claims abstract description 5
- 235000021120 animal protein Nutrition 0.000 claims abstract description 3
- 235000005911 diet Nutrition 0.000 claims description 14
- 230000037213 diet Effects 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 11
- 235000016709 nutrition Nutrition 0.000 claims description 10
- 241001528249 Frangula alnus Species 0.000 claims description 9
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 9
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 9
- 208000019901 Anxiety disease Diseases 0.000 claims description 7
- 230000036651 mood Effects 0.000 claims description 7
- 230000036506 anxiety Effects 0.000 claims description 6
- 239000003797 essential amino acid Substances 0.000 claims description 6
- 235000020776 essential amino acid Nutrition 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 6
- 235000021374 legumes Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 208000020401 Depressive disease Diseases 0.000 claims description 5
- 208000004880 Polyuria Diseases 0.000 claims description 5
- 230000035619 diuresis Effects 0.000 claims description 5
- 230000004580 weight loss Effects 0.000 claims description 5
- 240000005528 Arctium lappa Species 0.000 claims description 4
- 235000003130 Arctium lappa Nutrition 0.000 claims description 4
- 240000000171 Crataegus monogyna Species 0.000 claims description 4
- 244000163122 Curcuma domestica Species 0.000 claims description 4
- 244000021273 Peumus boldus Species 0.000 claims description 4
- 235000010841 Silybum marianum Nutrition 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 244000241257 Cucumis melo Species 0.000 claims description 3
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 3
- 244000019459 Cynara cardunculus Species 0.000 claims description 3
- 235000019106 Cynara scolymus Nutrition 0.000 claims description 3
- 241001186295 Lespedeza capitata Species 0.000 claims description 3
- 244000088415 Raphanus sativus Species 0.000 claims description 3
- 240000001949 Taraxacum officinale Species 0.000 claims description 3
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 3
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 3
- 235000016520 artichoke thistle Nutrition 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 235000008078 Arctium minus Nutrition 0.000 claims description 2
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 2
- OWNRRUFOJXFKCU-UHFFFAOYSA-N Bromadiolone Chemical compound C=1C=C(C=2C=CC(Br)=CC=2)C=CC=1C(O)CC(C=1C(OC2=CC=CC=C2C=1O)=O)C1=CC=CC=C1 OWNRRUFOJXFKCU-UHFFFAOYSA-N 0.000 claims description 2
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 2
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 2
- 241000208947 Cynara Species 0.000 claims description 2
- 235000003198 Cynara Nutrition 0.000 claims description 2
- 244000141009 Hypericum perforatum Species 0.000 claims description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 2
- 235000015933 Peumus boldus Nutrition 0.000 claims description 2
- 235000019057 Raphanus caudatus Nutrition 0.000 claims description 2
- 235000011380 Raphanus sativus Nutrition 0.000 claims description 2
- 241000320380 Silybum Species 0.000 claims description 2
- 244000272459 Silybum marianum Species 0.000 claims description 2
- 235000006754 Taraxacum officinale Nutrition 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 235000003373 curcuma longa Nutrition 0.000 claims description 2
- 230000000378 dietary effect Effects 0.000 claims description 2
- 239000008176 lyophilized powder Substances 0.000 claims description 2
- 239000012454 non-polar solvent Substances 0.000 claims description 2
- 239000012457 nonaqueous media Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 235000013976 turmeric Nutrition 0.000 claims description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims 1
- 108010064851 Plant Proteins Proteins 0.000 abstract description 2
- 235000021118 plant-derived protein Nutrition 0.000 abstract description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 14
- 229940076279 serotonin Drugs 0.000 description 7
- LDCYZAJDBXYCGN-UHFFFAOYSA-N 5-hydroxytryptophan Chemical compound C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 5
- 241000219774 Griffonia Species 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 3
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 208000030814 Eating disease Diseases 0.000 description 2
- 208000019454 Feeding and Eating disease Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000014632 disordered eating Nutrition 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical group 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000002858 neurotransmitter agent Substances 0.000 description 2
- 235000005974 protein supplement Nutrition 0.000 description 2
- 229940116540 protein supplement Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 230000036642 wellbeing Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical group 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Protein dietary supplement comprising at least one protein or amino acid mixture containing at least one plant protein and/or at least one animal protein, at least one first plant extract obtained from Griffonia simplicifolia having antidepressant action and at least one second plant extract obtained from one or more plants belonging to the genus Lespedeza with renal adjuvant action.
Description
TECHNICAL FIELD OF THE INVENTION
The present invention refers to a protein dietary supplement and, in particular, to a protein dietary supplement, comprising plant-based components.
STATE OF THE PRIOR ART
In the field of dietary supplements, protein dietary supplements have been known for some time. Such protein dietary supplements comprise a high quantity of proteins of various types and are usually used both for increasing muscular mass and for assisting in obtaining a quick and substantial weight loss.
Such protein dietary supplements can however be hard to digest and, due to the excess of proteins that they contain, they can cause a fatigue of renal functionality, since the kidneys are unable to correctly dispose of the provided protein supply.
In addition, during the periods of diet in which limited calorie quantities are consumed, due to the need to lose weight, and hence also during the periods of consumption of the aforesaid protein dietary supplements, it is possible that the user will experience the onset of anxiety and/or depressive states, with simultaneous sensations of anxiety, depression, insomnia or sleep disorder, restlessness, etcetera.
The same can occur in subjects with eating disorders, in which the correct calorie and/or nutritional supply is not sufficient, which are usually combined with a prevalent protein consumption with respect to that necessary or with respect to the other nutritional elements useful for the correct functionality of the organism and for the maintenance of a weight suitable for the physical and normal characteristics of the user.
In particular, serotonin is a substance that acts as neurotransmitter and has an action related to the mood and to the sleep. In particular, depression can be correlated to low levels of serotonin. Tryptophan is instead a slightly polar amino acid which is not synthesized by the human organism and hence must be obtained from foods: it is therefore classified among the essential amino acids. In addition to participating in the formation of the proteins of the organism,
tryptophan intervenes in numerous chemical reactions, in particular in the synthesis of serotonin and nicotinic acid.
In particular, tryptophan is a precursor of serotonin, of melatonin and niacin: the metabolite, intermediary between tryptophan and serotonin, is 5-hydroxytryptophan (5-HTP).
There is therefore the need to provide a protein dietary supplement capable of overcoming the above mentioned drawbacks.
OBJECTS OF THE INVENTION
One object of the present invention is to improve the state of the prior art.
Another object of the present invention is to provide a protein dietary supplement comprising components of plant origin.
A further object of the present invention is to provide a protein dietary supplement which can be easily digested and assimilated by the organism.
A further object of the present invention is to provide a protein dietary supplement capable of limiting renal fatigue, hence aiding diuresis and the disposal of the provided proteins.
Another object of the present invention is to provide a protein dietary supplement with cleansing properties which facilitate wellbeing.
A still further object of the present invention is to provide a protein dietary supplement capable of limiting the anxiety and/or depressive states in the user, hence helping in maintaining a good mood level.
In accordance with one aspect of the present invention, a protein dietary supplement is provided according to claim 1.
The dependent claims refer to advantageous characteristics of the invention.
EMBODIMENTS OF THE INVENTION
The present invention refers to a dietary supplement or protein dietary supplement, comprising a protein or amino acid mixture containing at least one plant protein and/or at least one animal protein and/or at least one amino acid, preferably an essential amino acid.
Such dietary supplement is adapted, e.g. in one version of the invention, to be consumed during the slimming diet periods or during periods of limited calorie consumption or during periods of mainly protein nutritional consumption.
Therefore, such supplement is used for a slimming treatment adapted to facilitate weight loss in a subject, in a slimming diet period, or in a period of limited calorie quantity consumption or in a period of mainly protein nutritional consumption.
Such dietary supplement is used in a treatment in order to limit the renal fatigue and/or to facilitate the diuresis and/or the disposal of the provided proteins, whether they are provided by the dietary supplement itself, for example, or provided by the diet during a slimming treatment for weight loss or during a slimming diet period or during a period of limited calorie quantity consumption or during a period of mainly protein nutritional consumption.
In addition, in one version of the invention, the dietary supplement is used for limiting or controlling the anxiety and/or depressive states and/or for maintaining a good mood level in the user during a slimming treatment period for weight loss or during a slimming diet period or during a period of limited calorie quantity consumption or during a period of mainly protein nutritional consumption.
In addition, such dietary supplement comprises at least one first plant extract and at least one second plant extract.
The first plant extract has antidepressant action; the second plant extract has renal adjuvant action.
The protein or amino acid mixture or the dietary supplement of the present invention can comprise at least one additional ingredient selected from among simple and/or complex carbohydrates, lipids, fibers, or minerals.
In addition, such protein or\amino acid mixture comprises at least one from among the essential amino acids, which are not synthesized by the organism, and in particular comprises tryptophan. Preferably, such protein mixture comprises isolated or free essential amino acids, i.e. not bonded in a protein chain. ~
The at least one first plant extract and the at least one second plant extract is obtained from at least one portion of the respective vegetable or plant.
In particular, the vegetable or plant portion from which the at least one first and/or the at least one second plant extract are obtained can be selected from among the leaves, bark, roots, rootstocks, stem, seeds and/or flowers, in accordance with the characteristics of the plant extract that one wishes to obtain or with the particular characteristics of the vegetable or plant, also in
accordance with the plant portions in which the active ingredients, which are desired to be present in the at least one first and/or in the at least one second plant extract, are contained.
Such at least one first and/or such at least one second plant extract can be present in the form of a powder, micronized powder, lyophilized powder, wet powder, aqueous and non-aqueous solutions, suspensions in non-polar solvents such as resins and oils, etcetera.
The at least one first plant extract or plant extract with antidepressant action according to the present invention comprises or is obtained from one or more of the below indicated plants, which contain active principles with antidepressant action, and/or tryptophan, and/or which stimulate the production, by the organism, of serotonin or niacin, and/or with anti-anxiety action, etcetera. In particular, the plants or vegetables having the following properties can be one or more of the following: plants of the legume family, Griffonia simplicifolia, Hypericum perforatum, Crataegus monogyna or common hawthorn, etcetera.
In particular, Griffonia simplicifolia is an African tropical plant of the legume family which acts as source of tryptophan and 5-HTP since it has a high content of the same. In particular, the seeds are composed for approximately 10% by 5-hydroxytryptophan (5-HTP), a molecule which determines the activity of the plant. When the legume is mature, the percentage of 5-HTP reaches the maximum content. . , '
As stated, 5-HTP is a metabolite intermediate between tryptophan and serotonin.
Therefore, the at least one plant extract of Griffonia simplicifolia of the present invention is capable of improving the mood level, the sexuality, the sleep quality, it facilitates the control of the pain threshold and assists in regularizing the sleep-awake cycle, body thermoregulation, the appetite, thus eliminating anxiety and depression.
Griffonia is an optimal aid for facilitating the mental wellbeing in subjects affected by anxiety states, insomnia or who require improving the mood level, such as in users subjected to slimming diets, in people with eating disorders, etcetera.
In particular the at least one first plant extract with antidepressant action or the plant extract of Griffonia is obtained from the seeds of such plant.
The at least one plant extract based on Griffonia assists in transforming the essential amino acids contained in the protein or amino acid mixture and to synthesize abovementioned neurotransmitters in order to limit the depressive states, generally typical of subjects who undergo slimming diets.
The at least one second plant extract or plant extract with renal adjuvant action of the present invention is also an extract capable of combating or assisting in the prevention or treatment of hyperazotemia and/or nephritis, renal insufficiency and/or, generally, it aids correct renal functionality, with consequent disposal of protein and of waste in general. Such aspect is very important, since a person who suffers the aforesaid pathologies or the aforesaid disorders is not capable of consuming proteins during normal feeding, with relative problems that can arise due to and as a consequence of this.
Such at least one second plant extract or extract with renal adjuvant action comprises or is obtained from one or more of the following plants: plants belonging to the genus Lespedeza, Lespedeza capitata Minch, artichoke (Cynara scolimus), boldo (Peumus boldus Mol.), black horseradish (Raphanus sativus), burdock (Arctium lappa L.), milk thistle (Silybum marianum), turmeric (Curcuma longa L.), birch, Taraxacum officinale, etcetera.
In one version, such second plant extract comprises components or active principles capable of aiding the correct renal functionality and/or the diuresis and/or the disposal of protein or of waste of the organism.
In a preferred version of the invention, the at least one second plant extract or plant extract with renal adjuvant action is obtained from one or more of the plants belonging to the genus Lespedeza, which confer an improved activity for the dietary supplement according to the present invention.
The plants belonging to the genus Lespedeza are grouped in about 40 species of flowering plants of the Fabaceae family.
Lespedeza, in particular Lespedeza capitata Mich, is a plant belonging to the legume family. Among the main constituents, the following are present: catechin tannins, catechols and flavonoids. The latter determine a cleansing action by Lespedeza or by the at least one second plant extract or plant extract with renal adjuvant action, since they have a particular chemical structure: the sugar of the glucoside is bonded to the flavone as glucosyl derivative. This bond ensures that the glucosides have much greater resistance to hydrolysis and can carry out a diuretic action for a long time period.
The at least one plant extract according to the present invention, in particular that deriving from Lespedeza, has a ACE-inhibitory action (typical activity of anti-hypertensive drugs). The
indications of this plant are therefore stimulation of diuresis and treatment of slight or medium hyperazotaemias .
The Lespedeza extracts can also be used for the capillary-protectant properties, in addition to the diuretic properties.
In particular the at least one second plant extract or plant extract with renal adjuvant action or the plant extract of Lespedeza is obtained from the leaves of such plant.
The dietary supplement according to the present invention can comprise, in one version of the invention, at least one extract of alder buckthorn (Rhamnus frangula) or an ingredient based on alder buckthorn (Rhamnus frangula) and/or at least one melon extract.
Alder buckthorn has, in one version of the invention, the property of stimulating the musculature of the intestine and thus facilitating the peristalsis and/or the production of mucus and/or the emptying of the intestine.
The at least one melon extract, in one version of the invention, has draining and/or anti-cellulite properties and/or is capable of facilitating skin nutrition.
With regard to the concentrations of the protein supplement according to the following invention, the protein or amino acid mixture has a concentration, by weight, based on the total weight of said dietary supplement, comprised between 60% and 99.8% or between 70% and 99% or between 80% and 98% or between 85% and 96% or between 90% and 93%.
In one version of the invention, the protein or amino acid mixture has a concentration by weight equal to about 60% of the overall weight of the dietary supplement according to the present invention.
In a further version, the protein or amino acid mixture has a concentration by weight equal to or greater than about 60% of the overall weight of the dietary supplement according to the present invention.
For such reason, the dietary supplement according to the present invention is defined a protein supplement, since it is composed for at least 60% by proteins and/or amino acids.
In a further version of the invention, the protein or amino acid mixture has a concentration by weight of at least 20% of the overall weight of the dietary supplement according to the present invention.
The at least one first plant extract or plant extract having antidepressant action has a concentration, by weight, based on the total weight of said dietary supplement, comprised
between 0.1% and 0.6% and preferably close to 0.25%, or between 0.15% and 2%, preferably close to 0.30%, if referred to the total weight of the protein or amino acid mixture.
Finally, the at least one second plant extract or plant extract with renal adjuvant action has a concentration, by weight, based on the total weight of said dietary supplement, comprised between 0.1% and 0.6% and preferably close to 0.25%, or between 0.15% and 2%, preferably close to 0.30%, if referred to the total weight of the protein or amino acid mixture.
In one version of the invention, the first plant extract or plant extract having antidepressant action has a concentration, by weight, equal to the concentration, by weight, of the second plant extract or plant extract with renal adjuvant action.
In particular, in one version of the invention, the concentration by weight of the Griffonia extract is equal to the concentration by weight of the Lespedeza extract.
In a still further embodiment of the invention, the at least one first plant extract or plant extract having antidepressant action and/or the at least one second extract or plant extract with renal adjuvant action have, each or overall, a concentration comprised between 1% and 15% by weight based on the total weight of the protein or amino acid mixture.
The dietary supplement according to the present invention is in the form of anhydrous powder or powder containing water or moisture.
In particular, the water or moisture present in the powder, in order to not activate the enzymes and the activity of the components of the dietary supplement and hence completely preserve the properties thereof intact up to the time of consumption by the user, is preferably less than 1% by weight based on the total weight of the dietary supplement.
The dietary supplement according to the present invention, in one version of the invention, is present in the form of a dry baked product or a food product having a water or moisture content less than 1% by weight based on the total weight of the dietary supplement.
The dietary supplement according to the present invention can be used for the preparation of dietary food, preferably dried or with a water or moisture content at 1 % by weight based on the total weight of the dietary supplement.
The dietary supplement according to the present invention can be used for introduction into daily meals.
According to a non-limiting embodiment of the present invention, the dietary supplement can comprise the following components (the indicated percentages are by weight):
Component % weight based on the total % weight based on the protein or amino acid mixture total
Proteins 71.0
Simple carbohydrates 1 1.4
Complex carbohydrates 2.2
Fibers 6.4
Lipids 1.2
Minerals 4.2
Griffonia 0.9 up to or over 1.26
Artichoke 0.18 up to 0.25
Dandelion 0.18 up to 0.25
Lespedeza 0.18 up to or over 0.25
The protein dietary supplement according to the present invention is susceptible of numerous modifications and variations, all falling within the inventive concept expressed in the enclosed claims.
All the details of the same can be substituted by other technically equivalent elements, and the materials can be different in accordance with the requirements, without departing from the scope of the invention.
Claims
1. Dietary supplement comprising at least one protein or amino acid mixture containing at least one vegetable protein and/or at least one animal protein, at least one first plant extract and at least one second plant extract, wherein said at least one first plant extract has antidepressant action and said at least one second plant extract has renal adjuvant action characterised in that said at least one second plant extract is obtained from one or more of the plants belonging to the genus Lespedeza.
2. Dietary supplement according to claim 1, wherein said at least one first plant extract and said at least one second plant extract is obtained from at least one portion of the respective plant, wherein said portion comprises leaves or bark or roots or rhizomes or stem or flowers or seeds.
3. Dietary supplement according to claim 1 or 2, wherein said at least one first plant extract with antidepressant action is obtained from one or more of the following plants: plants of the legume family, Griffonia simplicifolia, Hypericum perforatum, Crataegus monogyna or common hawthorn.
4. Dietary supplement according to claim 1 or 2, wherein said at least one second plant extract with renal adjuvant action is further obtained from one or more of the following plants: Lespedeza capitata Minch, artichoke (Cynara scolimus), boldo (Peumus boldus Mol.), black radish (Raphanus sativus), burdock (Arctium lappa L.), milk thistle (Silybum marianum), turmeric (Curcuma longa L.), birch, Taraxacum officinale.
5. Dietary supplement according to any one of the preceding claims, wherein said protein or amino acid mixture comprises essential amino acids and/or tryptophan.
6. Dietary supplement according to any one of the preceding claims, comprising at least one extract of alder buckthorn (Rhamnus frangula) or an ingredient based on alder buckthorn (Rhamnus frangula) and/or at least one melon extract.
7. Dietary supplement according to any one of the preceding claims, wherein said protein or amino acid mixture has a concentration, by weight, based on the total weight of said dietary supplement, higher than 20%, or equal to or higher than 60% by weight, or comprised between 60% and 99.8%, or between 70% and 99%, or between 80% and 98%, or even between 85% and 96%, or between 90% and 93%.
8. Dietary supplement according to any one of the preceding claims, wherein said at least one first plant extract has a concentration, by weight, based on the total weight of said dietary supplement, comprised between 0.1% and 0.6%, or near 0.25%, or has a concentration, by weight, based on the total weight of said protein or amino acid mixture, comprised between 0.15% and 2%, or near 0.30%, or comprised between 1% and 15%.
9. Dietary supplement according to any one of the preceding claims, wherein said at least one second plant extract has a concentration, by weight, based on the total weight of said dietary supplement, comprised between 0.1% and 0.6%, or near 0.25%, or has a concentration, by weight, based on the total weight of said protein or amino acid mixture, comprised between 0.15% and 2%, or near 0.30%, or comprised between 1% and 15%.
10. Dietary supplement according to any one of the preceding claims, wherein said protein or amino acid mixture comprises at least one additional ingredient selected from the group consisting of simple and complex carbohydrates, lipids, fibers, minerals.
11. Dietary supplement according to any one of the preceding claims, wherein said at least one first and/or said at least one second plant extract exists in the form of powder, micronized powder, lyophilized powder, wet powder, aqueous or non-aqueous solutions, suspensions in non-polar solvents such as resins and oils, etc.
12. Use of the dietary supplement according to any one of claims 1 to 11 for the preparation of food products or of dietary food or of an anhydrous powder or of a wet powder, or of a powder containing less than 1% by weight based on the total weight of the dietary supplement, of water or moisture, or of a dry baked product, or of a baked product or of a food product containing less than 1% by weight based on the total weight of the dietary supplement, of water or moisture.
13. Dietary supplement according to any one of claims 1 to 11, for use in one slimming treatment adapted to facilitate weight loss in a subject or in a slimming diet period or in a period of limited calorie quantity consumption or of mainly protein nutritional consumption.
14. Dietary supplement according to claim 13, for use in a treatment of limiting renal fatigue and/or of diuresis increase and/or of disposal of the proteins that are consumed by a subject by the diet and/or by the consumption of said dietary supplement during said slimming treatment or during said slimming diet period or during said period of limited calorie quantity consumption or of mainly protein nutritional consumption.
15. Dietary supplement according to claim 13, for use in a treatment of limiting or of control of the anxiety and/or depressive states and/or in maintaining a good mood level and/or in improving the mood in a subject during said slimming treatment or during said slimming diet period or during said period of limited calorie quantity consumption or of mainly protein nutritional consumption.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITVR2014A000234 | 2014-09-26 | ||
| ITVR20140234 | 2014-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2016046795A1 true WO2016046795A1 (en) | 2016-03-31 |
Family
ID=51982722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2015/057382 WO2016046795A1 (en) | 2014-09-26 | 2015-09-25 | Protein dietary supplement |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2016046795A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700085327A1 (en) * | 2017-07-26 | 2019-01-26 | Maria Grazia Milia | "COMPOSITION FOR THE PRODUCTION OF PASTA AND DERIVATIVES OF CEREALS, PSEUDO CEREALS AND SWEETS ADDED OF GRIFFONIA A A LOW GLYCEMIC INDEX" |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01186819A (en) * | 1988-01-18 | 1989-07-26 | Fumikatsu Otomo | Tea for activating renal function and beverage therefrom |
| BE1005963A7 (en) * | 1992-06-26 | 1994-04-05 | Pirmez Th | Use of Paullinia cupana in a phyto-active composition for losing excessweight or fatty tissue |
| WO1999061038A1 (en) * | 1998-05-29 | 1999-12-02 | Adams Food Ltd. | Composition having therapeutic and/or nutritionally active substituent |
| WO2002078746A1 (en) * | 2001-03-30 | 2002-10-10 | Altaffer, Paulo | Novel chocolate composition as delivery system for nutrients and medications |
| JP2003225072A (en) * | 2002-02-01 | 2003-08-12 | Suehito Yamagami | Health supplement having improving action of urinary disturbance |
| US20060040003A1 (en) * | 2004-08-10 | 2006-02-23 | Alvin Needleman | Dietary supplement for supressing appetite, enhancing and extending satiety, improving glycemic control, and stimulant free |
| WO2008149283A1 (en) * | 2007-06-05 | 2008-12-11 | Medestea Research & Production S.P.A. | Composition for supressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect |
| US20100074969A1 (en) * | 2008-09-19 | 2010-03-25 | Unicity International, Inc. | Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix |
| WO2013074531A1 (en) * | 2011-11-14 | 2013-05-23 | Requis Pharmaceuticals Inc. | Combination nutritional and nutraceutical products |
-
2015
- 2015-09-25 WO PCT/IB2015/057382 patent/WO2016046795A1/en active Application Filing
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01186819A (en) * | 1988-01-18 | 1989-07-26 | Fumikatsu Otomo | Tea for activating renal function and beverage therefrom |
| BE1005963A7 (en) * | 1992-06-26 | 1994-04-05 | Pirmez Th | Use of Paullinia cupana in a phyto-active composition for losing excessweight or fatty tissue |
| WO1999061038A1 (en) * | 1998-05-29 | 1999-12-02 | Adams Food Ltd. | Composition having therapeutic and/or nutritionally active substituent |
| WO2002078746A1 (en) * | 2001-03-30 | 2002-10-10 | Altaffer, Paulo | Novel chocolate composition as delivery system for nutrients and medications |
| JP2003225072A (en) * | 2002-02-01 | 2003-08-12 | Suehito Yamagami | Health supplement having improving action of urinary disturbance |
| US20060040003A1 (en) * | 2004-08-10 | 2006-02-23 | Alvin Needleman | Dietary supplement for supressing appetite, enhancing and extending satiety, improving glycemic control, and stimulant free |
| WO2008149283A1 (en) * | 2007-06-05 | 2008-12-11 | Medestea Research & Production S.P.A. | Composition for supressing appetite, improving tone and mood, with a natural antidepressant activity and with an antiasthenic effect |
| US20100074969A1 (en) * | 2008-09-19 | 2010-03-25 | Unicity International, Inc. | Method of controlling blood sugar levels, insulin levels, cholesterol levels, body fat levels, and body weight by administering a nutrient fiber matrix |
| WO2013074531A1 (en) * | 2011-11-14 | 2013-05-23 | Requis Pharmaceuticals Inc. | Combination nutritional and nutraceutical products |
Non-Patent Citations (3)
| Title |
|---|
| M RONDANELLI ET AL: "Satiety and amino-acid profile in overweight women after a new treatment using a natural plant extract sublingual spray formulation", INTERNATIONAL JOURNAL OF OBESITY, vol. 33, no. 10, 15 September 2009 (2009-09-15), pages 1174 - 1182, XP055192664, ISSN: 0307-0565, DOI: 10.1038/ijo.2009.155 * |
| MANOJLOVIC N T ET AL: "Antifungal activity of Rubia tinctorum, Rhamnus frangula and Caloplaca cerina", FITOTERAPIA, IDB HOLDING, MILAN, IT, vol. 76, no. 2, 1 March 2005 (2005-03-01), pages 244 - 246, XP027752373, ISSN: 0367-326X, [retrieved on 20050301] * |
| VENKATARAMANAN RAMAN ET AL: "In vitro and in vivo assessment of herb drug interactions", LIFE SCIENCES, vol. 78, no. 18, 27 March 2006 (2006-03-27), pages 2105 - 2115, XP028902912, ISSN: 0024-3205, DOI: 10.1016/J.LFS.2005.12.021 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700085327A1 (en) * | 2017-07-26 | 2019-01-26 | Maria Grazia Milia | "COMPOSITION FOR THE PRODUCTION OF PASTA AND DERIVATIVES OF CEREALS, PSEUDO CEREALS AND SWEETS ADDED OF GRIFFONIA A A LOW GLYCEMIC INDEX" |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103039400B (en) | Chicken raising method capable of improving egg quality | |
| CN104738451B (en) | A kind of olive oil chili oil and preparation method | |
| JP4113116B2 (en) | Pet food composition that regulates body weight and prevents obesity and related disorders in pets | |
| US20120244234A1 (en) | Nigella extracts for the treatment of symptoms connected to impaired or imbalanced neurotransmission | |
| CN101292724A (en) | Mushroom extractive flavouring and preparation method | |
| Adeyemi et al. | Effect of processing on the proximate and mineral compositions of Trachurus trachurus: A fish commonly consumed in Nigeria | |
| KR100346394B1 (en) | Meat of Duck Fed on Garlic and/or Oriental Medicines and Method of Feeding the Duck | |
| ELTAZI et al. | Effect of using garlic powder as natural feed additive on performance and carcass quality of broiler chicks | |
| CN101422268A (en) | Anti-cancer fish soup | |
| KR101635262B1 (en) | Bar type dietary food | |
| JP2008099652A (en) | Health food for metabolic syndrome | |
| WO2016046795A1 (en) | Protein dietary supplement | |
| Mohamed | Role of moringa, thyme and licorice leave extracts on productive performance of growing rabbits | |
| KR20180056607A (en) | Food manufacturing method | |
| Mahata | Importance of buckwheat (Fagopyrum esculentum Moench) | |
| CN102771748B (en) | Natural health-maintenance seasoning and preparation method thereof | |
| KR101365911B1 (en) | Processing methods for ham hocks ham hocks | |
| CN105901428A (en) | Mixed fish meal feed and preparation method thereof | |
| Mercola | Upgrade Your Immunity with Herbs: Herbal Tonics, Broths, Brews, and Elixirs to Supercharge Your Immune System | |
| CN104041820A (en) | Kidney-tonifying and spleen-tonifying health-maintaining porridge and preparation method thereof | |
| CN103947865A (en) | Pig forage capable of improving immunity and preparation method thereof | |
| Dronca et al. | Fenugreek-a dietary alternative component in animal feed. | |
| CN103652526A (en) | Prune jam and preparation method thereof | |
| CN107873960A (en) | A kind of growth promotion improves the Chinese herbal feed additive of meat quality of table poultry flavor and its prepares method | |
| CN107668326A (en) | A kind of fleshy duck fodder additive, preparation method and applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15804937 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 15804937 Country of ref document: EP Kind code of ref document: A1 |